Monday, June 29, 2020

Gilead Prices COVID-19 Drug At $2,340 Per Patient In Developed Nations

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the...

from NDTV News - Latest https://ift.tt/3dKZIH5
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Grounded Over Weight: Air India Tightens Fitness Norms For Cabin Crew

Non-compliance with the new standards could lead to de-rostering, grounding, and loss of pay for the affected personnel. from NDTV News Se...